Vistide
Product Images NDC 61958-0101

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Vistide (NDC 61958-0101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gilead Sciences, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Vistide 01)

Chemical structure of the active ingredient in Vistide, showing its molecular composition including an amine group, a pyrimidine ring, and a phosphonic acid moiety with two water molecules (dihydrate).*

FDA Label Image

Principal Display Panel (5 mL Vial Carton)

Vistide (cidofovir injection) 375 mg (75 mg/mL) single-use vial carton label. Each 5 mL vial contains 375 mg of cidofovir (anhydrous). The label highlights that the product is for intravenous infusion only and not for intraocular injection. Manufactured by Gilead Sciences, Inc., the packaging includes storage instructions and advises consulting the package insert for dosing and prescribing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.